Erratum: A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease (Atherosclerosis (2004) 174:2 (349-356) DOI: 10.1016/j.atherosclerosis.2004.01.030);A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease

Atherosclerosis

Volumn 174, Issue 2, 2004, Pages 349-356

  Ogasawara, Ken ^a   Mashiba, Shinichi ^b   Wada, Youichiro ^c   Sahara, Makoto ^a   Uchida, Kazuo ^b   Aizawa, Tadanori ^a   Kodama, Tatsuhiko ^c  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b Ikagaku Co Ltd   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherosclerosis; Coronary disease; Inflammation; Prognosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN INFARCTION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULITIS;

EID: 2342580664     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.06.006     Document Type: Erratum

References (28)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126
2. Berk B.C., Weintraub W.S., Alexander W. Elevation of C-reactive protein in "active" coronary artery disease. Am. J. Cardiol. 65:1990;168-172
3. Daneh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. Br. Med. J. 321:2000;199-204
4. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979
5. Haverkate F., Thompson S.G., Pyke S.D.M., et al. Prediction of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466
6. Ricker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843
7. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med. 331:1994;417-424
8. Biasucci L.M., Liuzzo G., Grillo R.L., et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 99:1999;855-860
9. Morrow D.A., Rifai N., Antman E.M., et al. Serum amyloid A predicts early mortality in acute coronaary syndromes: a TIMI 11A substudy. J. Am. Coll. Cardiol. 35:2000;358-362
10. Mueller C., Buettner H.J., Hodgson J.M., et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 105:2002;1412-1415
11. Choussat R., Montalescot G., Collet J.P., et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am. J. Cardiol. 86:2000;379-384
12. Thompson S.G., Kienast J., Pyke S.D.M., et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N. Engl. J. Med. 332:1995;635-641
13. Benditt E.P., Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA. 74:1977;4025-4028
14. Benditt E.P., Eriksen N., Hanson R.H. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 76:1979;4092-4096
15. Van Lenden B.J., Hama S.Y., de Beer F.C., et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response-loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96:1995;2758-2767
16. Marhaug G., Sletten K., Husby G. Characterization of amyloid related protein SAA complexed with serum lipoprotein (apoSAA). Clin. Exp. Immunol. 50:1982;382-389
17. Burstein M., Scholnick H.R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by presipitation with polyanions. J. Lipid Res. 11:1970;583-595
18. Goldstein J.L., Basu S.K., Brown M.S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:1983;241-260
19. Wada A., Yamada T., Itoh Y., et al. Sensitive enzyme-linked immunosorbent assay for human serum amyloid A and application to clearance study. Jpn. J. Clin. Pathol. 46:1998;1252-1257
20. Hatch F.T. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;1-68
21. Mashiba S., Wada Y., Takeya M., et al. In vivo complex formation of oxidized a1-antitrypsin and LDL. Arterioscler. Thromb. Vasc. Biol. 21:2001;1801-1808
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
23. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216
24. Robinson J.M., Badwey J.A. The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view. Histochem. Cell Biol. 103:1995;163-180
25. Ridker P.M., Rifai N., Clearfield M., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344:2001;1959-1965
26. Malle E., Steinmetz A., Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 102:1993;131-146
27. Yamada T., Kakihara T., Kamishima T., et al. Both acute phase and constitutive serum amyloid A are present in aterosclerotic lesions. Pathol. Int. 46:1996;797-800
28. Mackness B., Hunt R., Durrington P.N., et al. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;1233-1238